Loxo Oncology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Loxo Oncology generated cash of $107,763,000, which is more than the previous year. Cash used in financing activities reached the amount of $378,047,000 last year. Net change in cash is therefore $111,649,000.
Cash Flow
| 2014 | -17.69M | -69.08M | 115.71M |
|---|---|---|---|
| 2015 | -30.18M | -17.17M | 71.60M |
| 2016 | -51.31M | -26.48M | 40.00M |
| 2017 | 107.76M | -374.16M | 378.04M |
LOXO Cash Flow Statement (2014 – 2017)
| 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|
Cash at beginning of period | 30.37M | 68.17M | 43.93M | 14.99M |
Operating activities | ||||
Net income | -148.87M | -72.39M | -35.87M | -20.67M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 205K | 605K | 408K | 30K |
Stock-based compensation expense | 19.42M | 7.96M | 6.15M | 3.04M |
| Deferred income tax benefit | 19.42M | 7.96M | 6.15M | 3.04M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 8.45M | 11.49M | 30K | 18K |
Cash generated by operating activities | 107.76M | -51.31M | -30.18M | -17.69M |
Investing activities | ||||
Purchases Of Investments | -574.50M | -163.29M | -133.73M | -74.56M |
Investments In Property Plant And Equipment | -789K | -237K | -93K | -14K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -374.16M | -26.48M | -17.17M | -69.08M |
Financing activities | ||||
Common Stock Issued | 375.30M | 38.73M | 71.29M | 74.33M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | -142.02M | -30.37M | -68.17M | -43.93M |
Repayments of term debt | 0 | 0 | 0 | -1.79M |
Cash used in financing activities | 378.04M | 40.00M | 71.60M | 115.71M |
Net Change In Cash | 111.64M | -37.80M | 24.24M | 28.93M |
Cash at end of period | 142.02M | 30.37M | 68.17M | 43.93M |
| Data source | Data source | Data source | Data source |